Arkolith/Insider Trading/IMMX/Form 4

Hsu Jason

DirectorImmix Biopharma, Inc. (IMMX) · full profile →Form 4 · filed Aug 26, 2024
Net Buying
Open-Market Buys
$52K
Open-Market Sells
$0
Net Open-Market Flow
$52K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2024Buy(P)8K$2.25$18K845K
Aug 21, 2024Buy(P)15K$2.23$33K837K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-033900) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML